Breech External Cephalic Version Intervention Trial
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Jan 30, 2019
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Breech External Cephalic Version Intervention Trial is studying a procedure called external cephalic version (ECV) to help turn babies that are in a breech position, meaning their feet or buttocks are down instead of their head. This trial is currently looking for women who are 18 years or older and can give their written consent to participate. However, women under 18, those with certain pregnancy complications like placenta previa, or those with fetal abnormalities are not eligible to join.
If you decide to participate, you will receive care related to this procedure, which aims to improve the chances of a safe delivery by turning the baby into a head-down position. The study is actively recruiting participants, so if you or someone you know fits the eligibility criteria and is interested, it could be a great opportunity to contribute to important research in pregnancy care.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Presence of the written consent of the patients.
- • The patients must be over 18 years old .
- • No limit in the ability to consent.
- Exclusion criteria:
- • Age under 18
- • Limited ability to consent
- • Placenta previa
- • Fetal abnormalities
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin Mitte, , Germany
Patients applied
Trial Officials
Larry Hinkson, FRCOG
Principal Investigator
Consultant in Obstetrics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials